Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination CagriSema in Adults With or Without Diabetes REDEFINE 1 & 2 Cagrilintide 2.4 mg + Semaglutide 2.4 mg once weekly 20.4% weight loss (non diabetic) & 13.7% (T2D) Cagrilintide and semaglutide together drive record weight loss in global trial Cagrilintide 10mg NewBioRx Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management Retatrutide vs Tirzepatide vs Semaglutide comparison Voy